Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503091 | SCV000595957 | likely pathogenic | Nemaline myopathy 2 | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000503091 | SCV004300643 | pathogenic | Nemaline myopathy 2 | 2023-11-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala834Profs*9) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 435967). For these reasons, this variant has been classified as Pathogenic. |